COPD: Illness severity, resource utilisation and cost

Irish Medical Journal

Volumn 98, Issue 2, 2005, Pages 41-45

  Tynan, Aodan J ^a   Lane, S J ^b  

^a GLAXOSMITHKLINE   (Ireland)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID DERIVATIVE; OXYGEN;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH CARE SYSTEM; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INTERVIEW; IRELAND; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MEDICAL RESEARCH; PRESCRIPTION; RESOURCE ALLOCATION; SYMPTOMATOLOGY; DRUG THERAPY; ECONOMICS; EMERGENCY HEALTH SERVICE; HOSPITALIZATION; MIDDLE AGED; PRIMARY HEALTH CARE; UTILIZATION REVIEW;

AGED; DRUG THERAPY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; IRELAND; MALE; MIDDLE AGED; PRIMARY HEALTH CARE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SEVERITY OF ILLNESS INDEX;

EID: 18944392152     PISSN: 03323102     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Rennard S, Decramer M, Calverley PM et al. Impact of COPD in North America and Europe in 2000: subjects' perspective of Confronting COPD International Survey. Eur Respir J 2002; 20:1-7.
2. Guest J F. The Annual Cost of Chronic Obstructive Pulmonary Disease to the UK's National Health Service. Disease Management and Health Outcomes 1999; 5(2):93-100.
3. Jansson SA, Andersson F, Borg S, Ericsson A, Jonsson E, Lundback B. Costs of COPD in Sweden according to disease severity. Chest 2002; 122(6):1994-2002.
4. MIMS Ireland, August 2002.
5. Charlson M., Szatrowski T P, Peterson J., Gold J. Validation of a combined comorbidity index. J Clin Epidemiol 1994; 47(11).
6. Bestall JC, Paul EA, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999; 54:581-6.
7. Hurd S, Pauwels R. Global Initiative for Chronic Obstructive Lung Diseases (GOLD). Pulm Pharmacol Ther 2002; 15(4):353-5.